Mr. Mucus helps Reckitt dominate cough-and-cold space

What's the key to landing your brand on the leaderboard of cough-and-cold meds? Mr. Mucus, apparently. The Reckitt Benckiser spokes-character has propelled Mucinex to three of the top four slots on a new list of preferred OTC products, according to online data-analysis company Treato. More from FiercePharmaMarketing

Suggested Articles

Merck is scouting replacements for CEO Ken Frazier with a preference toward an internal candidate, Bloomberg reports.

Bluebird Bio says the launch of Zynteglo, its first gene therapy, will not occur until 2020 while it tightens up its manufacturing processes.

Riival generics makers are squashing long-running lawsuits over their own versions of Sanofi's big-selling blood thinner Lovenox.